MBio raises $5.2 million for new offerings
BOULDER — mBio Diagnostics Inc., a Boulder-based biotech company, has raised $5.2 million in an equity offering.
The company has a total offering amount of $6.4 million, according to a Form D filed with the U.S. Securities and Exchange Commission on Aug. 21.
The funds will be used to scale the business as it forms new partnerships, including one that will use its platform for veterinary testing, CEO Chris Myatt told BizWest.
“We’re in an expansion and growth mode,” he said.
MBio makes a portable testing system that can test on site. One of its tests can detect toxic green…
THIS ARTICLE IS FOR SUBSCRIBERS ONLY
Continue reading for less than $3 per week!
Get a month of award-winning local business news, trends and insights
Access award-winning content today!
Related Posts
-
Ann Schmiesing, vice chancellor and executive vice provost for Academic Resource Management at the University…
-
TiFin Group , a Boulder-based financial technology umbrella company, has offloaded its ownership stake in…
-
Downtown Boulder’s Business Improvement District is recruiting two at-large board members.
-
Broomfield-based Premier Members Credit Union opened a new branch this week at 1425 S. Airport…
